Thermo Fisher Scientific Inc. (NYSE:TMO) yesterday revealed plans for its third expansion project in China within the last 12 months.
The company intends to open a laboratory instruments manufacturing plant in the Suzhou municipality in early 2012.
The Medical Device Business Journal — Medical Device News & Articles | MassDevice
Thermo Fisher Scientific Inc. (NYSE:TMO) yesterday revealed plans for its third expansion project in China within the last 12 months.
The company intends to open a laboratory instruments manufacturing plant in the Suzhou municipality in early 2012.
MASSDEVICE ON CALL — Heart disease? Stay happy to survive, says study. Coronary artery disease patients with an optimistic outlook on their recovery are more likely to survive longer than those with negative outlooks, new research published in the Archives of Internal Medicine suggests. For the study, about 2,800 heart disease patients were given a questionnaire that asked them about their belief in their ability to recover.
I’m flying back from Japan to the U.S. today and on the way I purchased a vegan (soy) Green Tea Latte from Starbucks. I relish the Japanese version of this beverage because it is unsweetened (even a bit bitter), since the Japanese typically do not like sugary foods and drinks. As I ordered the beverage, the clerk behind the counter handed me a special quality control token to ensure I would not receive any dairy products.
Sluggish electronic medical record sales growth in 2010 was caused by uncertainty over federal guidelines, according to a new report.
Healthcare market research firm Kalorama Information predicted 15 percent growth rate for EMR system sales in both 2009 and 2010, but the market achieved only 10 and 13.6 percent, respectively.
Electronic medical record firm Practice Fusion Inc. promoted former PayPal Inc. executive Jason Portnoy to be the company’s CFO.
Portnoy was the CFO of Palo Alto-based information analytics firm Palantir Technologies Inc. before joining Practice Fusion in November as vice president of finance.
Here’s a roundup of the latest dealflow and investment news:
By Stewart Eisenhart, Emergo Group
A medical alert system developed by wireless communications company Ascom Holding AG (SWX:ASCN) received 510(k) clearance from the Food & Drug Administration, and now the company is gearing up to bring the new offering to its installed customer base of nearly 1,200 U.S. hospitals.
Boston Scientific (NYSE:BSX) is getting a big boost this morning, climbing as much as 6 percent in early trading after RBC Capital Markets reportedly raised its rating for the medical device maker’s stock.
BSX shares touched $7.62 apiece early today, before backing down to its current range of about $7.50 per share. The stock last traded this high just one week ago, before sliding nearly 7 percent between Tuesday and Thursday’s close.